Every record from Janoshik · page 34
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020869 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 98.41 | 5.42 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020834 | SS-31 (Elamipretide) | SGN | SGN-2507-U1475 | 2025-Q4 | 97.25 | 4.52 | 90.9 | Supplier-supplied | 1 | FAIL |
| AX-2025-020228 | Cagrilintide | GGPeps | GGPE-2507-Y1706 | 2025-Q4 | 97.77 | 1.47 | 90.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019782 | Ipamorelin | HJ | HJ-2511-D4010 | 2025-Q4 | 99.01 | 4.49 | 103.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019660 | SS-31 (Elamipretide) | Homopeptide | HOMO-2507-B2039 | 2025-Q4 | 99.31 | 5.56 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019002 | PT-141 (Bremelanotide) | FGP | FGP-2509-H2645 | 2025-Q4 | 99.93 | 2.87 | 88.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018593 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.14 | 4.22 | 88.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020097 | ARA-290 | GGPeps | GGPE-2511-F8277 | 2025-Q4 | 98.89 | 2.34 | 99.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020095 | ARA-290 | GGPeps | GGPE-2511-F8277 | 2025-Q4 | 99.36 | 2.28 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020017 | TB-500 | ERP | ERP-2511-L7123 | 2025-Q4 | 98.81 | 4.58 | 99.3 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019591 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.87 | 6.01 | 94.3 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019173 | AOD-9604 | TFC | TFC-2511-L5476 | 2025-Q4 | 99.62 | 3.29 | 103.3 | Supplier-supplied | 1 | FAIL |
| AX-2025-021274 | Semaglutide | BCH | BCH-2505-Y7460 | 2025-Q4 | 98.21 | 6.41 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020202 | Enclomiphene citrate | GGPeps | GGPE-2510-H1237 | 2025-Q4 | 99.93 | 5.07 | 101.6 | Supplier-supplied | 1 | FAIL |
| AX-2025-021099 | Semaglutide | WXT | WXT-2507-N4828 | 2025-Q4 | 97.31 | 4.52 | 97.9 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020986 | Tirzepatide | CPC | CPC-2506-E3505 | 2025-Q4 | 97.74 | 4.95 | 89.6 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020831 | SS-31 (Elamipretide) | SGN | SGN-2507-U1475 | 2025-Q4 | 97.36 | 4.36 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020091 | ARA-290 | GGPeps | GGPE-2511-F8277 | 2025-Q4 | 99.03 | 2.25 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019629 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 98.92 | 6.50 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019522 | MK-677 (Ibutamoren mesylate) | Homopeptide | HOMO-2506-L9801 | 2025-Q4 | 99.81 | 1.50 | 106.3 | Supplier-supplied | 1 | FAIL |
| AX-2025-018589 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.49 | 4.03 | 94.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020437 | Tirzepatide | KP | KP-2506-B4700 | 2025-Q4 | 97.60 | 4.07 | 104.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020411 | Tirzepatide | KP | KP-2505-F4869 | 2025-Q4 | 96.85 | 5.96 | 100.0 | Buyer-sourced | 1 | FAIL |
| AX-2025-020201 | Enclomiphene citrate | GGPeps | GGPE-2510-H1237 | 2025-Q4 | 99.93 | 6.07 | 93.9 | Supplier-supplied | 0 | FAIL |
| AX-2025-018914 | Semaglutide | FGP | FGP-2506-J9812 | 2025-Q4 | 99.70 | 4.71 | 105.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018488 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.18 | 4.11 | 100.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021121 | TB-500 | WXT | WXT-2507-J5534 | 2025-Q4 | 98.96 | 3.82 | 103.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020476 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.11 | 5.18 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020156 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.29 | 6.71 | 92.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019052 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B3061 | 2025-Q4 | 99.93 | 4.28 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018888 | Ipamorelin | QSC | QSC-2508-X9836 | 2025-Q4 | 99.59 | 2.35 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021209 | Gonadorelin | BCH | BCH-2510-F6239 | 2025-Q4 | 99.33 | 5.16 | 97.7 | Supplier-supplied | 0 | PASS |
| AX-2025-021068 | Semaglutide | WXT | WXT-2505-P4630 | 2025-Q4 | 99.69 | 5.05 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019446 | GHRP-2 | Homopeptide | HOMO-2505-T8504 | 2025-Q4 | 99.52 | 4.64 | 103.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019352 | Semaglutide | TFC | TFC-2507-K7301 | 2025-Q4 | 98.18 | 5.40 | 90.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019258 | Selank | TFC | TFC-2511-C6410 | 2025-Q4 | 99.93 | 8.34 | 99.4 | Supplier-supplied | 0 | PASS |
| AX-2025-018753 | TB-500 | QSC | QSC-2505-C7889 | 2025-Q4 | 99.03 | 3.58 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018584 | ARA-290 | QYB | QYB-2511-Y5015 | 2025-Q4 | 99.93 | 5.61 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020469 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.08 | 4.70 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020150 | Sermorelin | GGPeps | GGPE-2508-U8736 | 2025-Q4 | 99.17 | 4.20 | 96.2 | Supplier-supplied | 1 | MARGINAL |